Document Preview Unavailable
Effectiveness of XBB.1.5 Monovalent COVID-19 Vaccines During a Period of XBB.1.5 Dominance in EU/EEA Countries, October to November 2023: A VEBIS-EHR Network Study
Monge, Susana; Humphreys, James; Nicolay, Nathalie; Braeye, Toon; Izaak Van Evercooren; et al. Influenza and Other Respiratory Viruses Vol. 18, Iss. 4, (Apr 2024).You might have access to this document
-
Try and log in through your institution to see if they have access to the full text.
Log in through your library